Ruling gives green light for controversial COVID-19 therapy
12/12/2020 No Comments
The evidence provided by AIFA was not enough to limit the individual doctors’ decisional autonomy; the ban on hydroxychloroquine was reversed on 11 December.
The evidence provided by AIFA was not enough to limit the individual doctors’ decisional autonomy; the ban on hydroxychloroquine was reversed on 11 December.